February 2012

Spinal Cord Stimulation Effective for HIV Neuropathy

At the 6th World Congress of the World Institute of Pain in Miami Beach this month, Dr. Kenneth Candido presented a poster on the success of implanting a permanent device that delivers constant spinal cord stimulation to offer pain relief to patients with HIV-related polyneuropathy. Dr. Candido is chair and professor in the Department of …

Spinal Cord Stimulation Effective for HIV Neuropathy Read More »

Publication of Phase III Study Shows Positive Results for Diabetic Neuropathic Pain

The results of a 13-week study by Avanir Pharmaceuticals, published in the journal Pain Medicine, show efficacy and safety of AVP-923 for treatment of diabetic neuropathic pain. Currently also in study for multiple sclerosis, the combination of Dextromethorphan and Quinidine (AVP-923) showed its effectiveness in treating diabetic neuropathic pain, particularly a reduction in leg pain. READ …

Publication of Phase III Study Shows Positive Results for Diabetic Neuropathic Pain Read More »

Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests

A new study from University of Michigan researchers found that the most efficient testing is not always done for peripheral neuropathy – especially diabetes related neuropathy. Led by Dr. Brian Callaghan, Assistant Professor of Neurology, the team found that many tests can be given but physicians are highly variable in approach. There is a lot …

Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests Read More »

EpiCept Files for AmiKetâ„¢ Fast Track Designation

EpiCept Corporation announced that it has filed for Fast Track designation for AmiKet, their new topical cream to be used in the treatment of chemotherapy-induced peripheral neuropathy. The Fast Track program, created by the FDA, is designed to facilitate development and expedite review of drugs intended to treat serious or life-threatening conditions and address unmet …

EpiCept Files for AmiKetâ„¢ Fast Track Designation Read More »

Fighting Off Cancer Does Cost

In a study from the Colorado Cancer Center, results have shown that using Oxaliplatin for the treatment of colorectal cancer causes Oxaliplatin-induced neurotoxicity (OXIN). One way to avoid immediate symptoms from the drug is to use a ‘stop and go’ treatment cycle giving the drug with breaks in between treatments. The study was published in …

Fighting Off Cancer Does Cost Read More »